Interviews/Contributions Investor Insights: Sabir Rassiwalla – How Has MedTech’s Changing Landscape Brought You to CRG? (Part 1) Shared by Ken Dropiewski on August 26, 2022 More in Interviews/Contributions: Investor Insights: Tasneem Dohadwala I Excelestar Ventures – Investment Stage and Amount June 25, 2025 Investor Insights with Tasneem Dohadwala of Excelestar Ventires: Refining Investment Focus June 4, 2025 Investor Insights: Greg Garfield of KCK MedTech – How does he see 2025 playing out May 2, 2025 Share this story Facebook Twitter LinkedIn McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about what drove him to CRG after a long tenure with Abbott.